Besides, HCC-derived TGF-β increased the expression of TIM-3 on TAMs, which enhanced tumor immune tolerance and stimulated tumor growth via NF-κB/IL-6 pathway (131). Here, TGFB1 is linked to hepatocellular carcinoma.